ACI Clinical is pleased to be a sponsor at the upcoming 2016 Endpoint Adjudication Forum in Philadelphia on October 19-20, 2016. Highlights of the conference include a presentation and discussion on industry best practice, performance standards by ACI’s EAC Lead, Shaena Kaufman, on Wednesday, October 19 at 2:45 p.m. as well as the Adjudicator Panel discussion moderated by ACI’s Manager of Members Services, Bill Stedman, on Thursday, October 20 at 9:15 a.m.

Other confirmed speakers include:

  • Sylvie Bartus, Ph.D.
  • Lisa G. Berdan, PA, MHS
  • Sharon Blank
  • Arundhati Datye
  • Peter H. Eriksen
  • Jesse Fishman
  • Bill Haddock
  • W. Schuyler Jones, M.D.
  • Raju Joshi
  • Scott Kasner, M.D., MSCE
  • Terry Katz
  • Richard J. Lee, M.D., Ph.D.
  • Kenneth Mahaffey
  • Andrea Maynard
  • Ashley Mondello
  • Alison Occhiuti
  • Karla Saldivar
  • Bill Stedman
  • Andrew Van Tosh, M.D., FACC
  • Ralph J. Verdino, M.D.
  • Richard Walovitch, Ph.D.
  • Matthew Wilson


About the Conference



About ExL Events
ExL Events, Inc., (aka “ExL Pharma”) develops engaging, content-driven conferences and partnered events for dynamic industry audiences, including pharmaceutical, biotechnology, medical device, diagnostic and contract research organizations; hospital networks; physicians; and communications and other entities. Behind their diverse event portfolio, their experienced team conducts extensive market research and targeted outreach. The results translate into innovative, high-quality events that facilitate the exchange of critical information between industry professionals and suppliers who support shared goals.

About ACI Clinical
ACI Clinical is a specialty provider of clinical trial advisory services and clinical trial committees, such as Endpoint Adjudication and Data Monitoring Committees. ACI has been a CDISC-registered solution provider for many years and maintains deep involvement in several public-private thought leadership efforts to improve the quality and effectiveness of clinical trials. ACI actively participates in current projects with the Cardiac Safety Research Consortium (CSRC), the Clinical Trials Transformation Initiative (CTTI), and the Multi-Regional Clinical Trials Center (MRCT).